Vimarsana
Biggest News Aggregation in the World

Page 7 - Scientific Presentations News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Scientific Presentations. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Scientific Presentations Today - Breaking & Trending Today

Tonix Pharmaceuticals : Announces Data Presentations Involving TNX-1500 (Fc-modified anti-CD40L mAb) for the Prevention of Rejection in Kidney and Heart Allograft Transplantation in Animal Models at the 2022 American Transplant Congress - Form 8-K - Vimarsana News

Tonix Pharmaceuticals : Announces Data Presentations Involving TNX-1500 (Fc-modified anti-CD40L mAb) for the Prevention of Rejection in Kidney and Heart Allograft Transplantation in Animal Models at the 2022 American Transplant Congress - Form 8-K

Tonix Pharmaceuticals Holding Corp. , a clinical-stage biopharmaceutical company, today announced data from three oral presentations at the 2022 American Transplant Congress by faculty at the Center... | June 9, 2022

Phathom Pharmaceuticals to Present Data at DDW 2022 Annual Meeting - Vimarsana News

Phathom Pharmaceuticals to Present Data at DDW 2022 Annual Meeting

17.05.2022 - New investigational data evaluating vonoprazan in erosive esophagitis (EE) Research highlights real-world evidence of unmet needs that exists for the treatment of Helicobacter pylori (H. pylori) infection Phathom research recognized with multiple ... Seite 1

Aligos Therapeutics to Present Data for its Clinical - Vimarsana News

Aligos Therapeutics to Present Data for its Clinical

SOUTH SAN FRANCISCO, Calif., Oct. 14, 2021 (GLOBE NEWSWIRE) -- Aligos Therapeutics, Inc. (Nasdaq: ALGS), a clinical stage biopharmaceutical company...

Blue Earth Diagnostics Announces Axumin (Fluciclovine F 18) Presentations at Upcoming 2021 American Society of Clinical Oncology (ASCO) Annual Meeting - Vimarsana News

Blue Earth Diagnostics Announces Axumin (Fluciclovine F 18) Presentations at Upcoming 2021 American Society of Clinical Oncology (ASCO) Annual Meeting

Blue Earth Diagnostics, a Bracco company and recognized leader in the development and commercialization of innovative PET radiopharmaceuticals, today highlighted presentations at the 2021 American Society

Molecular Partners : Shares New Preclinical Data from its AML-Focused CD3 T-Cell Engager Program, CD40 Product Candidate MP0317, and Other Novel Immuno-oncology Approaches at AACR - Vimarsana News

Molecular Partners : Shares New Preclinical Data from its AML-Focused CD3 T-Cell Engager Program, CD40 Product Candidate MP0317, and Other Novel Immuno-oncology Approaches at AACR

Molecular Partners Shares New Preclinical Data from its AML-Focused CD3 T-Cell Engager Program, CD40 Product Candidate MP0317, and Other Novel Immuno-oncology Approaches at AACR ... | April 11, 2021